Clinical Trials Directory

Trials / Completed

CompletedNCT02550171

BioGene Bank Cohort Study for Approved Research Requests

The BioGene Bank Cohort Study is a Collection of Human Blood Samples (DNA and Plasma) Along With De-identified (Coded) Health Information, Questionnaire Responses on Environment and History of Family Disease to be Used for Research

Status
Completed
Phase
Study type
Observational
Enrollment
7,056 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers
Accepted

Summary

The BioGene bank: Is a centralized collection of human blood samples along with de-identified (coded) health information, environmental factors, family disease histories and information from DNA. Limited to the NSLIJHS catchment area.

Detailed description

The purpose of the BioGene Bank Cohort is to collect blood and store DNA from blood, along with health information to study how genetic variation in the population is associated with particular diseases, treatments and medical outcomes. Investigators may study the entire range of diseases and medical problems that exist within the NSLIJHS, including medical, surgical, psychiatric, pediatric and obstetric conditions. The specimens and medical information will be kept at a central Biorepository. This research study does not involve any treatment and individual research results are not provided.

Conditions

Timeline

Start date
2009-03-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2015-09-15
Last updated
2016-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02550171. Inclusion in this directory is not an endorsement.